TORSILIFE PLUS
NEFROCASA
Top

TORSILIFE PLUS

MRP: 820

Packaging: 10x10

Pack Type: tablet

Composition:

Spironolactone 50mg + Torasemide 10mg

Indication:

EDEMA Associated with Secondary Hyperaldosteronism in Liver Cirrhosis, Congestive Heart Failure Nephrotic syndrome Hypertension with Hyperaldosteronism

Description:

This potent combination tablet combines Spironolactone (50 mg), a potassium-sparing diuretic and aldosterone antagonist, with a higher dose of Torasemide (10 mg), a loop diuretic with strong diuretic and antihypertensive effects.

This formulation is used to treat edema associated with congestive heart failure, liver cirrhosis, nephrotic syndrome, and other conditions involving fluid overload. The synergistic action allows enhanced removal of excess fluid while minimizing potassium loss, improving electrolyte balance and patient compliance.

Tags:

Diuretics Edema Management Heart Failure Liver Cirrhosis Electrolyte Balance Hypertension
  • Powerful reduction of fluid overload in edema and ascites
  • Balances potassium while promoting effective diuresis
  • Used for managing heart failure, liver cirrhosis, nephrotic syndrome
  • Helps control high blood pressure associated with fluid retention
  • Enhances patient compliance with once or twice-daily dosing

Usage Information

Dosage

Adults: Usually 1 tablet once daily or as prescribed Take with food to reduce gastric irritation Dose may be adjusted based on clinical response and electrolyte monitoring

Side Effects

Dizziness, headache, gastrointestinal discomfort Electrolyte imbalances such as hyperkalemia or hyponatremia Gynecomastia or hormonal effects from spironolactone Increased urination, dehydration risk Rare allergic reactions or kidney impairment

Contraindications

Elevated potassium levels (hyperkalemia) Severe renal failure or anuria Addison’s disease or adrenal insufficiency Known allergy to spironolactone or torasemide Pregnancy and breastfeeding (consult physician)